Tatiana Andia
Title
Cited by
Cited by
Year
Definition and classification of generic drugs across the world
R Alfonso-Cristancho, T Andia, T Barbosa, JH Watanabe
Applied health economics and health policy 13 (1), 5-11, 2015
682015
Higher pharmaceutical public expenditure after direct price control: improved access or induced demand? The Colombian case
SI Prada, VE Soto, TS Andia, CP Vaca, ÁA Morales, SR Márquez, ...
Cost Effectiveness and Resource Allocation 16 (1), 1-8, 2018
322018
Making knowledge legitimate: transnational advocacy networks' campaigns against tobacco, infant formula and pharmaceuticals
T Andia, N Chorev
Global Networks 17 (2), 255-280, 2017
122017
First evaluation of Colombian’s external reference pricing system
T Andia, A Gaviria, C Gómez, LF Jaramillo, S Márquez, I Rodríguez, ...
Value in Health 17 (3), A15, 2014
122014
Is the judicialization of health care bad for equity? A scoping review
TS Andia, E Lamprea
International journal for equity in health 18 (1), 1-12, 2019
112019
The invisible threat: trade, intellectual property, and pharmaceutical regulations in Colombia
T Andia
Intellectual Property, Pharmaceuticals, and Public Health: Access to Drugs …, 2011
102011
El “efecto portafolio” de la regulación de precios de medicamentos: La respuesta de la industria farmacéutica a la regulación de precios de medicamentos en colombia”
T Andia
Washington, DC https://doi. org/10.18235/0001305, 2018
72018
Pharmaceutical Intellectual Property Rights Protection and Access to Medicines in Ecuador–State Sovereignty and Transnational Advocacy Networks
T Andia
Balancing Wealth and Health–the Battle for Intellectual Property and Access …, 2014
62014
The invisible threat: the rise of non-intellectual property and non-trade pharmaceutical regulations in Colombia
T Andia
Intellectual Property, Pharmaceuticals and Public Health: Access to Drugs in …, 2011
62011
Tutelas en Salud y paradoja de los Medicamentos de Marca versus los Medicamentos Genéricos en Colombia
T Andia
Vitae 20 (2), 93-94, 2013
52013
The Inverse Boomerang Pattern: the Global Kaletra Campaign and Access to Antiretroviral Drugs in Colombia and Ecuador
T Andia
Studies in Comparative International Development 50 (2), 203-227, 2015
32015
Extracting low-cost signals of quality control in community pharmacies: a simulated client study in Bogotá
T Andia, C Mantilla, A Morales, S Ortiz, P Rodríguez
Universidad del Rosario Documentos de Trabajo, 2020
22020
El “efecto portafolio” de la regulación de precios de medicamentos
T Andia
La respuesta de la industria farmacéutica a la regulación de precios de …, 2018
22018
Information and symptoms assessment in community pharmacies during the COVID-19 pandemic: An audit study in Colombia
T Andia, C Mantilla, P Rodrıguez-Lesmes, L Criado, J Sebastián Gómez, ...
Journal of Behavioral Economics for Policy 4 (S2), 5-14, 2020
12020
Pharmaceutical Intellectual Property Rights Protection and Access to Medicines in Ecuador
T Andia
Balancing Wealth and Health: The Battle Over Intellectual Property and …, 2014
12014
Does price-cap regulation work for increasing access to contraceptives? Aggregate-and pharmacy-level evidence from Colombia
P Rodríguez, T Andia, C Mantilla, Á Morales, S Ortiz
Universidad del Rosario Documentos de Trabajo, 2020
2020
Does price-cap regulation work for increasing access to contraceptives? Aggregate-and pharmacy-level evidence from Colombia
T Andia, C Mantilla, A Morales, S Ortiz, P Rodriguez
SocArXiv, 2020
2020
Mentioning anosmia improves how community pharmacies handle phone call requests during the COVID-19 pandemic: An audit study in Colombia
T Andia, C Mantilla, P Rodriguez-Lesmes, L Criado, JS Gomez, S Ortiz, ...
SocArXiv, 2020
2020
Health Litigation and the Paradox of Branded versus Generic Drugs in Colombia
T Andia
Vitae 20 (2), 93-94, 2013
2013
LOCAL MALADIES, GLOBAL REMEDIES: RETHINKING RIGHT TO HEALTH DUTIES
E Lamprea, T Andia
The system can't perform the operation now. Try again later.
Articles 1–20